Just 14 months ago, Bloomington officials were ecstatic when contract drugmaker Catalent announced a huge plant expansion in their city. But in a head-spinning turn of events, Catalent has since announced two large rounds of layoffs at the Bloomington plant.... Read More
An Indianapolis-based supplier of oxygen kits, nebulizers and other home health care products is being sued in connection with a massive data breach of personal information and for waiting more than 18 months to report it.... Read More
Eli Lilly and Co. announced Tuesday morning it is buying a California biopharmaceutical company in a deal worth about $2.4 billion as it looks to expand its presence in skin diseases and immunology disorders.... Read More
Zakiyyah Darden claims that public disclosure of her medical information turned her life upside down. In court filings, she says her fiancé broke off their engagement after finding out about her diagnosis and kicked her out of his house. Her co-workers and supervisor at her warehouse job made comments, causing her to leave her job. She also lost several clients at her hairdressing business.... Read More
Lutheran Hospital in Fort Wayne, one of only three Indiana hospitals to perform organ transplants, is closing its heart transplant and inpatient burn services, citing low volumes. The move marks the end of Lutheran Hospital’s transplant program. ... Read More
Eli Lilly and Co. has agreed to pay $13.5 million to settle class-action lawsuit that alleged Lilly systematically overpriced its insulin. The settlement covers older insulins in Lilly’s portfolio sold under the brand names Humalog, Humulin, and Basaglar. ... Read More
An Indianapolis-based radiopharmaceutical company said Friday it plans to help open a facility in Belgium to make therapeutic agents for European cancer patients.... Read More
Syra Health Corp., a two-year-old Carmel startup that provides professional services in the health care and life science industries, is planning to go public. Syra said it expects the offering to raise up to $8 million with its initial public offering.... Read More
A federal judge has tripled the damages in a jury verdict against Eli Lilly and Co., ruling that the drugmaker must pay $183.7 million in a lawsuit filed by a whistleblower who said the company made false claims about rebates to the federal Medicaid program.... Read More
It is meant to help Hoosiers get more affordable prices on prescription drugs on everything from blood-pressure medications to chronic-pain treatments .But whether Senate Enrolled Act 8 will have far-reaching ramifications remains a very open question.... Read More
